Posted On: 03/11/2016 2:22:06 PM
Post# of 30015
Quote:
The FDA granted the Xalkori expanded use application breakthrough therapy designation and priority review status.
Thats not the same as a PRV voucher is it?
And even if it is, why can't AMBS still get one?
Maybe i'm missing something?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)